Over the past two decades, research has linked persistent STAT3 activation to a wide range of diseases, including bone‐related diseases [11], cardiovascular diseases [12], inflammatory diseases [13], autoimmune disorders [14], neurodegenerative diseases [15], and various cancers [16]. This evidence concerns the gene STAT3 and cancer.